Skip links

Leadership

Our global expertise is your asset.
We rethink innovation.

By coupling our unmatched experience in transformative technologies such as Artificial Intelligence and Blockchain with vast competencies in healthcare, Life Sciences, Biotech, and Pharma, we rethink innovation. Alongside unparalleled Private Equity, Policy, and Regulation expertise.

As international renowned experts we serve C-Suites, leading multinationals to start-ups, governments, investors, academia, and non-profit organizations worldwide. By guiding our clients in their digital transformation and innovation strategies with pragmatic and actionable solutions.

Nicole Formica-Schiller

CEO & Founder
More about Nicole

Mel Formica

Member of the Board
More about Mel

Nicole Formica-Schiller

CEO & Founder

Nicole Formica-Schiller is a prominent figure in the European AI and global innovation ecosystem and advisor to industry, politics and academia. Forbes selected her for “most innovative ideas” in AI and Blockchain.

As CEO of Pamanicor Health in Switzerland, she founded one of the first global advisory firms leveraging Artificial Intelligence (AI) and Blockchain with Life Science, Digital Health, Biotech, Venture Capital, Private Equity, Digital Policy, Data.

She is well-known for advising Boards, SMEs and corporations in transformative solutions, strategic direction and operational implementation of digital initiatives. As well as her ability to translate complex digital trends of tomorrow into use cases of today. Aligned with corporate strategy, regulatory requirements and data-driven business models to drive excellence in execution.

With her interdisciplinary background as digital innovation expert, lawyer and economist, Nicole Formica-Schiller got appointed as “OECD AI Expert”. Leveraging her competencies in strategic tech, policy and geopolitics. Providing AI-specific policy advice to OECD – OCDE’s Committee on Digital Economy Policy (CDEP).

Renowned for her expertise in AI regulation, governance, digital sovereignty, Nicole Formica-Schiller was one of the initial contributors to EU AI Act negotiations with representatives from the European Commission and Parliament, as well as Governments.

She advises parliaments, ministries and commissions including the German parliament and Federal Ministry for Economic Affairs, Data Ethics Commission, Digital Ministry Bavaria, Australian Trade Investment Commission, Bavarian Ministry of Economic Affairs, and others as a subject matter expert.

She has been appointed to various Boards including the Board of German Israeli Health Forum for AI (GHIF-AI), advising German and Israeli Health Ministries. As well as the Board of the German AI Association where Nicole Formica-Schiller played a key role shaping one of Europe’s largest AI and Start-up ecosystems. Heading also its Steering Committee “EU AI Regulation – EU AI Act” and co-authoring the position paper “EU Regulation of Artificial Intelligence” submitted to national and EU stakeholders.

As Board member on the “International Advisory Board Digital Science & Interdisciplinary Technologies” of Paris Lodron University Salzburg (PLUS) in Austria Nicole Formica-Schiller provides strategic advice for establishing its new Faculty Digital & Analytical Sciences (e.g. Human Computer Interaction). Including curriculum, a research college, selecting Professors, Phds, Post-Docs and guiding the Steering and Scientific Board.

Nicole Formica-Schiller is regularly featured in the media (e.g. Frankfurter Allgemeine Zeitung (FAZ), Handelsblatt, E-Health-Com, Tagesspiegel, NTV, National Geographic, Breaking Through), with The London Financial portraying her as “internationally recognized AI expert”.

Nicole Formica-Schiller is appointed as role model in AI and digital professions by former Bavaria’s Digital Minister patronaged by Prime Minister Dr. Markus Söder. As digital thought leader she is a sought-after speaker at (inter-)national level.

As part of her ongoing publications her “top pre-order” listed book “AI and Blockchain in Healthcare: COVID-19 and future-oriented technologies revolutionizing the Status quo” (Elsevier) is a wake-up call!

Before founding Pamanicor Health, Nicole Formica-Schiller pursued a successful career across Europe, US, and Asia at Nord Stream (CEO Liaison Officer) involved in one of Europe’s largest stakeholder consultations, paving the way for European governmental approvals and policies across different jurisdictions, at Freshfields (IT / IP), Shearman Sterling, Allianz. She graduated as an Attorney-at-law from the prestigious Ludwig-Maximilians-University Munich, Germany, with an additional economics and business degree. As well as Public Policy from Blavatnik School of Government, Oxford University.

Recent articles (exemplary)

„We help our customers implement disruptive technologies and shape the future“
Interview with CEO & Founder Nicole Formica-Schiller

“European Health Data Space: Transforming health data access and sharing”
Statement “Regulation” by Data and Policy expert Nicole Formica-Schiller

“Artificial Intelligence as push for Innovation in Life Sciences and Healthcare”
Call to Action by Nicole Formica-Schiller

“Four questions about Artificial Intelligence in Healthcare”
To Digital Expert Nicole Formica-Schiller

Mel Formica, PhD, MBA

Member of the Board

Regarded as one of the leading transformation leaders in Life Sciences, Biopharmaceuticals and Digital Healthcare, Mel Formica is globally recognized as an innovative and sought-after healthcare executive. He is a highly respected international expert with proven P&L and operational leadership experience as well as M&A advisory expertise. An innovator in developing distinctive market entry and commercial strategies for early-stage businesses, combining customer insight, vision, and creativity. Focused at the forefront of transformations in Disruptive Technologies, patient level data and improved quality of care.

With over 20+ years of industry experience in leadership roles at world leading companies such as at Envision Pharma Group, Evidera / PPD, Takeda Pharmaceuticals, Amgen Inc., IMS Health and Abbot Laboratories across Australia, US, China, Japan, Switzerland, and Europe. His extensive experience spans clinical research, marketing, strategic consulting, value & access, and evidence generation which makes him a sought-after leader for C-Suites and innovative companies worldwide. As an operating advisor to private equity firms focused on healthcare, he challenges portfolio companies to think about long-term changes and strategically position new opportunities in the market.

Mel Formica is well known in the industry as a pioneer of breakthrough concepts, global biopharmaceutical product launches and new organizational models leading to improved operating efficiency and driving business growth. With international experience to successfully drive top and bottom-line growth through building and leading complex organizations, strategic transformations, turnarounds as well as leading cross-functional teams spanning multiple geographies and complex matrix organizations.

With a vision to change the way the industry thinks, acts, and operates, Mel Formica is the co-founder of the BCG Market Access Roundtable and the London School of Economics and Political Science (LSE) Market Access Academy. He has also been featured in numerous industry and scientific publications and received various awards.

His academic and research appointments included Assistant Professor at the College of Physicians and Surgeons of Columbia University, New York, St. Luke’s-Roosevelt Hospital Center, New York and Helen Hayes Hospital, New York, US.

Mel Formica earned his PhD (Medicine) at the University of Melbourne, Australia. He completed his post-doctoral training in the Department of Medicine at Columbia University, New York, US. In addition, he holds an Executive MBA from the Lubin School of Business, Pace University, New York, US.